版本:
中国

BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package

April 28 Novartis AG:

* Says U.S. wholesale acquisition cost of Rydapt for AML indication is $7,495 for 14-day package and $14,990 for 28-day package - spokeswoman Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐